Viewing Study NCT00004204


Ignite Creation Date: 2025-12-24 @ 8:02 PM
Ignite Modification Date: 2025-12-31 @ 12:14 AM
Study NCT ID: NCT00004204
Status: UNKNOWN
Last Update Posted: 2014-01-06
First Post: 2000-01-21
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Temozolomide in Treating Patients With Recurrent or Progressive Malignant Glioma
Sponsor: Herbert Irving Comprehensive Cancer Center
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Description Module Conditions Module Design Module Arms Interventions Module Eligibility Module Contacts Locations Module